Dr. Christian Weiss

Advise, Invest and Value Creation for Sovereignty by design for wealth, health and critical infrastructure. xVC GP, xMcK.

📍 Germany🔄 Updated September 2026💼 8 investments📅 10 years investing🗓 Last invested Nov 2021
VC🌍 Germany
8
Total investments
5
Early stage
2
Mid stage
1
Late stage
10y
Years active

Portfolio

8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Nov 2021
FORMEL SKIN is a HealthTech start-up with the mission to offer individualised, high-quality medical treatments online. We solve multiple challenges facing dermatologists and patients today. Patients register online, complete a questionnaire and upload photos of their concerns. A personal doctor is assigned to the patient and will decide on the medical treatment required and adjust the treatment monthly in line with patient feedback and results. This treatment is created by pharmacies and then shipped to the patient monthly. We are backed by Europes most prominent early stage VCs, Cherry Ventures and Heartcore Capital.
Investor
Jan 2021
Elevating the patient experience and providing the best possible care by combining technology with a human touch.
Investor
Jun 2020
Our mission: Make healthcare accessible, convenient, and affordable for all by automating primary care from symptom to outcome. Our Medical Guidance Platform is a set of intelligent healthcare technologies that enables early symptom assessment and digital triage, and supports communication between physicians and patients. At the core of Infermedica’s technologies are its Medical Knowledge Base, Inference Engine and API gateway. The platform minimizes the inappropriate use of medical services, and improves patient navigation and user satisfaction. Symptom-checking features provided by Infermedica can be freely implemented on webpages, mobile apps, and patient portals via API or ready-to-use triage and intake modules. Patient safety is the main focus of physicians, engineers, and scientists working, side-by-side, at Infermedica. The algorithms use dynamic interview scenarios to predict the lists of possible conditions. They analyze common language and verify combinations of symptoms. Infermedica modules are certified Medical Devices in the EU and compliant with HIPAA and GDPR standards. We have been adeptly interweaving medical and technical expertise into our technologies since 2012, to support industry leaders such as Global Excel, Gothaer, Médis, Microsoft, and Sana Kliniken. Infermedica is now being used in more than 30 countries and 20 languages, and has completed more than 14 million successful health checks to date. To learn more about the company and its products, visit infermedica.com. Also check out Symptomate, our consumer-facing symptom checker. Available for free use at symptomate.com User data is processed by Infermedica in accordance with the terms of the service and the data protection laws – GDPR for branding, communication and networking etc. All information about processing of your data and your rights can be found in the Privacy Policy on Infermedica.com or via dpo@infermedica.com.
Investor
May 2020
CereGate is a Brain-Machine Interface company establishing new ways of communication Together with our partners we are driven to develop new ways of interfacing with the human brain through the latest technology. Our mission is to provide patients with neurological disorders or sensory deficits with new opportunities to adapt and improve their condition under their own power. Increasing patient independence while improving quality of life are our guiding principles.
Investor (acquired by Doctolib)
Jun 2019
This page is no longer active. To simplify our communications, all content related to Doctolib Connect is now centralised and shared on the main Doctolib LinkedIn page. You will continue to find content dedicated to Doctolib Connect, designed to address your needs and use cases, along with updates tailored to your region. 👉 We invite you to follow the @Doctolib LinkedIn page to stay informed. Join over one million healthcare professionals on Doctolib Connect for secure, efficient communication and seamless care coordination. With its intuitive design and the highest standards of data security, Doctolib Connect ensures you can manage patient care and discuss complex cases with confidence.
Investor (acquired by Quest Diagnostics)
2017
Blueprint Genetics is a genetic diagnostics company focused on inherited diseases. We provide world-class genetic diagnostics and clinical interpretation for hereditary diseases. We are passionate about changing peoples’ lives through development of groundbreaking solutions that take genetic diagnostics from niche to mainstream. Our global team of innovative and motivated people are working at the forefront of genetic knowledge, AI and other areas of life science. Our team consists of more than 20 nationalities working as geneticists, data analysts, laboratory technicians, client service specialists, genetic services consultants, software developers and marketing specialists. Today, we work with customers in over 70 countries and push to make genetic knowledge easier to access for the medical community. Our comprehensive and cost-effective genetic tests support healthcare professionals around the world in providing the best care for patients and families with rare inherited diseases.
Investor / Board Member
2016
HUMANOOs leading corporate health & wellbeing platform is trusted by over 600 organizations across the globe to support & manage the health of their people. HUMANOO’s platform enables you to understand, nurture, and seamlessly manage your health & well-being initiatives by providing you with aggregated & anonymized insights into the well-being of your employee base. HUMANOO’s holistic approach to health & well-being ensures that the needs of diverse workforces are all addressed within one single solution. Among others, the employee offering includes: - Over 3000+ Video & Audio Coachings (fitness, yoga, mindfulness, sleep, nutrition) - 1-on-1 sessions with coaching experts (e.g. mindfulness, nutrition) - 16+ types of team & company challenges (e.g. steps, mindfulness) - Rewards for health activities (e.g. cash backs, vouchers, donations to sustainability causes)
Investor / Board Member (acquired by Bosch)
2016
In 2014, COBI.Bike GmbH was founded as a start-up in Frankfurt by Andreas Gahlert, Carsten Lindstedt, Heiko Schweickhardt and Tom Acland. Since its acquisition by Bosch eBike Systems in November 2017, the company has been a 100% subsidiary of Robert Bosch GmbH. The company promotes the networking of people, services and products on bikes or eBikes. About the COBI.bike Product The smart biking system COBI.Bike stands for connected biking and connects smartphones, apps and sensors to bikes and eBikes. It consists of the COBI.Bike hub, the thumb controller and the app. COBI.Bike ensures that you remain connected to the digital world even while on the bike. The thumb controller and the COBI.Bike app control the safe and convenient access to bike navigation, fitness data, telephone or music while cycling and users are connected to other apps such as komoot or Strava if they wish. Additional hub features such as a charging function for smartphones, an automatic AmbiSense light system and an alarm system provide even more comfort, safety and fun on every ride. The COBI.Bike system was designed for all bikes and works with virtually every smartphone.
Experience · 13 entries
All (13)
Investments (8)
Board (2)
2024
Advisor
2024
Please write us at hi@naturalx.vc if you like to share funding rounds. naturalX Health Ventures is a €100 million venture capital fund focused on Consumer Health, with the mission to transform healthcare from reactive to proactive. The fund supports science-driven solutions at the intersection of wellness and medicine that extend lifespan, healthspan, and brainspan, enabling people to live longer, healthier, and more fulfilling lives. naturalX invests at Series A and Series B stages across Europe and the U.S.
2022
Venture Partner
2022
We reimagine healthcare by leveraging cutting-edge technology to make a difference in people‘s lives. Heal Capital is one of Europe’s leading dedicated investment funds for integrated HealthTech with a total investment volume of EUR 100m, backed by the German private health insurers. We back mission-driven founders with capital and HealthTech-specific expertise, accelerating market access to the healthcare system. Register to our newsletter to receive the lastest information on our events in your mailbox! https://healcapital.typeform.com/to/tnypj2L8
2021
Investor
Nov 2021
FORMEL SKIN is a HealthTech start-up with the mission to offer individualised, high-quality medical treatments online. We solve multiple challenges facing dermatologists and patients today. Patients register online, complete a questionnaire and upload photos of their concerns. A personal doctor is assigned to the patient and will decide on the medical treatment required and adjust the treatment monthly in line with patient feedback and results. This treatment is created by pharmacies and then shipped to the patient monthly. We are backed by Europes most prominent early stage VCs, Cherry Ventures and Heartcore Capital.
Investor
Jan 2021
Elevating the patient experience and providing the best possible care by combining technology with a human touch.
2020
Investor
Jun 2020
Our mission: Make healthcare accessible, convenient, and affordable for all by automating primary care from symptom to outcome. Our Medical Guidance Platform is a set of intelligent healthcare technologies that enables early symptom assessment and digital triage, and supports communication between physicians and patients. At the core of Infermedica’s technologies are its Medical Knowledge Base, Inference Engine and API gateway. The platform minimizes the inappropriate use of medical services, and improves patient navigation and user satisfaction. Symptom-checking features provided by Infermedica can be freely implemented on webpages, mobile apps, and patient portals via API or ready-to-use triage and intake modules. Patient safety is the main focus of physicians, engineers, and scientists working, side-by-side, at Infermedica. The algorithms use dynamic interview scenarios to predict the lists of possible conditions. They analyze common language and verify combinations of symptoms. Infermedica modules are certified Medical Devices in the EU and compliant with HIPAA and GDPR standards. We have been adeptly interweaving medical and technical expertise into our technologies since 2012, to support industry leaders such as Global Excel, Gothaer, Médis, Microsoft, and Sana Kliniken. Infermedica is now being used in more than 30 countries and 20 languages, and has completed more than 14 million successful health checks to date. To learn more about the company and its products, visit infermedica.com. Also check out Symptomate, our consumer-facing symptom checker. Available for free use at symptomate.com User data is processed by Infermedica in accordance with the terms of the service and the data protection laws – GDPR for branding, communication and networking etc. All information about processing of your data and your rights can be found in the Privacy Policy on Infermedica.com or via dpo@infermedica.com.
Show all 13 entries ↓
Investment activity
2016–2021 · 8 investments
2016220171201912020220212
Recent (last 2 years)Earlier